Report Overview

The Brazil Glaucoma Therapeutics market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Glaucoma is a leading cause of blindness. This generally happens due to raised intraocular tension. The main therapeutic goal is to lower the intraocular tension. This is done either by reducing the secretion of aqueous humour or increasing its drainage. Although the drugs of glaucoma reduce the symptoms, there is no complete cure for this condition.



Market Drivers

There is currently an increasing prevalence of glaucoma among the elderly population. The increasing screen time of gadgets such as laptops and smart phones among the geriatric population is further aiding in the rising incidence of glaucoma. There are numerous pipeline products under development for the treatment of glaucoma.

Major Types of Glaucoma

Based on disease indication, the market is segmented into open angle glaucoma, angle closure glaucoma, and others. The open angle glaucoma segment dominated the market and is estimated to maintain its position over the forecast duration. This is because of high prevalence of the disorder, as compared to the other types of glaucoma. Additionally, majority of the glaucoma therapeutic drugs currently available are indicated to treat open angle glaucoma making it the leading segment in the category.